tiprankstipranks
Trending News
More News >

Allan Reine Insider Profile

4 Followers
Allan Reine, CFO at Palvella Therapeutics, holds 53.78K shares in Foghorn Therapeutics (Ticker: FHTX), holds ― shares in Palvella Therapeutics (Ticker: PVLA), holds ― shares in Prime Medicine, Inc. (Ticker: PRME).
tipranks
Allan Reine

Allan Reine
Palvella Therapeutics (PVLA)
CFO

Not Ranked
Allan Reine has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$243K
100.00%
0.00%
0.00%
A breakdown of Allan Reine's holdings

Insider Roles

Foghorn Therapeutics
(FHTX)
CFO
Palvella Therapeutics
(PVLA)
CFO
Prime Medicine, Inc.
(PRME)
CFO
Roles that Allan Reine holds in companies

Most Profitable Insider Trade

Stock:
Palvella Therapeutics
(PVLA)
Rating:Informative Buy
Date:Aug 17, 2017 - Aug 17, 2018
Return:+9.90%
The most profitable trade made by Allan Reine

Allan Reine's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Palvella Therapeutics
Aug 17, 2017
CFO
Informative Buy
313.35K
Foghorn Therapeutics
Aug 11, 2021
CFO
Uninformative Buy
100.04K
$243.10K
Prime Medicine, Inc.
CFO
List of latest transactions for each holding click on a transaction to see Allan Reine's performance on stock

Allan Reine insider profile FAQ

What is the percentage of profitable transactions made by Allan Reine?
The percentage of profitable transactions made by Allan Reine is ―.
    What is the average return per transaction made by Allan Reine?
    The average return per transaction made by Allan Reine is ―.
      What stocks does Allan Reine hold?
      Allan Reine holds: PVLA, FHTX, PRME stocks.
        What was Allan Reine’s latest transaction?
        Allan Reine latest transaction was an Uninformative Buy of $100.04K.
          What was Allan Reine's most profitable transaction?
          Allan Reine’s most profitable transaction was an Informative Buy of PVLA stock on August 17, 2017. The return on the trade was 9.90%.
            What is Allan Reine's role in Palvella Therapeutics?
            Allan Reine's role in Palvella Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.